Becker's Healthcare October 7, 2024
Elizabeth Gregerson

The U.S. spent $99 billion on both oral and clinician-administered cancer therapies in 2023, according to a report published in April by analytics firm IQVIA. As cancer drug prices continue to increase, spending is projected to grow.

Here are five things to know about cancer drug spending in the U.S.:

  1. The U.S.’ $99 billion spending on cancer drugs in 2023 represented 45% of global cancer drug spending.
  2. Cancer drug spending in the U.S. is expected to increase...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
Related Articles:
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article